Securities and Exchange Commission
Washington, D.C. 20549
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(A)
of the Securities Exchange Act of 1934
Filed by the Registrant [ ]
Filed by a Party other than the Registrant [X]
Check the appropriate box:
[ ] Preliminary Proxy Statement
[ ] Definitive Proxy Statement
[X] Definitive Additional Materials*
[ ] Soliciting Material Pursuant to Section 240.14a-11(c)
or Section 240.14a-12
Circon Corporation
(Name of Registrant as Specified in its Charter)
United States Surgical Corporation
(Name of Person Filing Proxy Statement)
----------------------------
Payment of Filing Fee (Check the appropriate box):
[X] No fee required.
[ ] Fee computed on table below per Exchange Act Rules
14a-6(i)(4) and 0-11.
(1) Title of each class of securities to which
transaction applies: N/A
(2) Aggregate number of securities to which
transaction applies: N/A
(3) Per unit price or other underlying value of
transaction computed pursuant to Exchange Act Rule
0-11 (Set forth the amount on which the filing fee
is calculated and state how it was determined): N/A
(4) Proposed maximum aggregate value of transaction:
N/A
(5) Total fee paid: N/A
[ ] Fee previously paid with preliminary materials.
[ ] Check box if any part of the fee is offset as
provided by Exchange Act Rule 0-11(a)(2) and
identify the filing for which the offsetting fee was
paid previously. Identify the previous filing by
registration statement number, or the Form or
Schedule and the date of its filing.
(1) Amount previously paid:
(2) Form, Schedule or Registration Statement Number:
(3) Filing Party:
(4) Date Filed:
____________________
* Although the attached press release is being filed as additional material
pursuant to Rule 14a-6 under the Securities Exchange Act of 1934,
the filer of this additional material does not believe that this press
release constitutes soliciting material.
FOR IMMEDIATE RELEASE: August 13, 1997
Contacts: U.S. Surgical
INVESTOR CONTACT: U.S. SURGICAL HOME PAGE MEDIA CONTACT:
Marianne Scipione http://www.ussurg.com Steve Rose
Vice President Director
Corporate Communications Media Relations
(203) 845-1404 (203) 845-1732
UNITED STATES SURGICAL CORPORATION
FILES SUIT AGAINST CIRCON CORPORATION
NORWALK, CT. -- United States Surgical Corporation
(NYSE:USS) said today that it has filed suit against Circon
Corporation (NASDAQ: CCON) asking the Court of Chancery in the
State of Delaware to order Circon to hold its 1997 Annual
Meeting of Shareholders.
In addition, USS today reinstated its lawsuit in the Court
of Chancery seeking to compel Circon to provide USS with
information necessary to enable USS to communicate directly
with Circon's shareholders concerning its tender offer and
proxy contest to elect two directors to Circon's board and
seeking approval of a shareholder resolution at the Annual
Meeting. USS has repeatedly requested this information from
Circon, but Circon has not yet provided all the requested
information.
United States Surgical Corporation is a diversified
surgical products company specializing in minimally invasive
technologies that improve patient care and lower health costs.
